SOME FACTORS ASSOCIATED WITH SEPTIC SHOCK AND MORTALITY IN DIABETES AND SEPTICEMIA PATIENTS

Ngân Tạ Thị Diệu, Yến Đoàn Thị Hải

Main Article Content

Abstract

Retrospective study of 176 patients diagnosed diabetes with septicemia, hospitalized at the National Hospital for Tropical Diseases from 2016 to 2021 to investigate factors associated  with septic shock and mortality in these patients. Septicemia was confirmed by clinical cricteria and positive blood culture. Results: The rate of septic shock in the study was 17.06%, the mortality rate was 9.1%. There was no difference in blood glucose and HbA1c levels at admission between patients with septic shock and without septic shock, between survivors and non-survivors, and between gram-positive septicememia and gram-negative septicemia. Multivariate logistic regression analysis showed that Glasgow score <15 (OR = 4.876; 95%CI: 1.635-14.545; p=0.04) and CRP levels at admission (OR=1.005; 95%CI 1.001-1.009, p=0.018) were independent prognostic factors for septic shock. Septic shock is an independent prognostic factor for mortality in diabetic patients with septicemia (OR = 33.355; 95%CI: 4.124-269.743; p=0.001). Conclusion: In diabetic patients with septicemia, there was no association between blood glucose and HbA1c levels at admission with septic shock and mortality. Independent prognostic factors for septic shock were impaired consciousness and CRP levels at admission. Independent prognostic factor for mortality was septic shock.

Article Details

References

1. Patterson CC, Harjutsalo V, Rosenbauer J, et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration study. Diabetologia. 2019;62(3):408-417. doi:10. 1007/s00125-018-4763-3
2. Dwyer-Lindgren L, Mackenbach JP, Lenthe FJ van, Flaxman AD, Mokdad AH. Diagnosed and Undiagnosed Diabetes Prevalence by County in the U.S., 1999–2012. Diabetes Care. 2016;39(9):1556-1562. doi:10.2337/dc16-0678
3. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26(3-4): 259-265. doi:10.1111/j.1574-695X.1999. tb01397.x
4. Peleg AY, Weerarathna T, McCarthy JS, Davis TME. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev. 2007;23(1):3-13. doi:10.1002/dmrr.682.
5. Elisa Costantini, Massimiliano Carlin, Massimo Porta , Maria Felice Brizzi. Type 2 diabetes mellitus and sepsis: state of the art, certainties and missing evidence; Acta Diabetol. 2021 May 10;58(9):1139–1151. doi: 10.1007/ s00592-021-01728-4 .
6. Gornik I, Gornik O, Gašparović V. HbA1c is outcome predictor in diabetic patients with sepsis. Diabetes Research and Clinical Practice. 2007; 77(1): 120-125. doi:10.1016/j.diabres.2006. 10.017;
7. Lavanya K. Study on the role of HbA1c as a prognostic factor in type 2 diabetes patients with sepsis. Published online April 2017. doi:10/2/ 200100117.
8. Nghiêm Huyền Trang, Tạ Thị Diệu Ngân, “Các nhiễm khuẩn thường gặp ở bệnh nhân đái tháo đường điều trị tại Bệnh viện Bệnh Nhiệt đới Trung ương (4/2016-3/2018)”, Tạp chí Truyền nhiễm Việt Nam, Số 4 (24), 2018; 18-23.
9. Peralta G, Sánchez MB, Roiz MP, Garrido JC, Teira R, Mateos F. Diabetes does not affect outcome in patients with Enterobacteriaceae bacteremia. BMC Infect Dis. 2009;9:94. doi:10.1186/1471-2334-9-94.
10. Wang Z, Ren J, Wang G, Liu Q, Guo K, Li J. Association Between Diabetes Mellitus and Outcomes of Patients with Sepsis: A Meta-Analysis. Med Sci Monit. 2017;23:3546-3555. doi:10.12659/ MSM.903144